Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review.
CONCLUSIONS: The use of metformin was associated with a reduced risk of HCC, and it may be a relevant factor for preventing HCC in diabetic patients.
PMID: 31836424 [PubMed - as supplied by publisher]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
More News: Aspirin | Bactrim | Cancer & Oncology | Carcinoma | Cholesterol | Databases & Libraries | Diabetes | Endocrinology | Fortamet | Gastroenterology | Hepatocellular Carcinoma | Insulin | Liver Cancer | Metformin | Science | Statin Therapy | Study